Eric Druyts
Overview
Explore the profile of Eric Druyts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan K, Balijepalli C, Gullapalli L, Joshy J, Kotum S, Druyts E
Curr Med Res Opin
. 2024 Aug;
40(10):1741-1752.
PMID: 39166959
Background: To review the literature to outline findings from clinical trials assessing interventions for metastatic castration-resistant prostate cancer (mCRPC) in patients who have progressed on androgen receptor-axis-targeted (ARAT) therapies. Methods:...
2.
Li J, Yan K, Balijepalli C, Druyts E
Curr Med Res Opin
. 2024 Feb;
40(4):709-722.
PMID: 38328952
Objective: To systematically review the literature and summarize the health-related quality-of-life (HRQoL) of patients undergoing treatment for mucopolysaccharidoses (MPS), a rare, hereditary lysosomal storage disorder. Methods: A systematic review was...
3.
Shui I, Scherrer E, Frederickson A, Li J, Mynzhassarova A, Druyts E, et al.
Melanoma Res
. 2022 Oct;
32(6):393-404.
PMID: 36223314
Nearly half of advanced melanoma patients do not achieve a clinical response with anti-programmed cell death 1 protein (PD1) therapy (i.e. primary resistance) or initially achieve a clinical response but...
4.
Balijepalli C, Yan K, Gullapalli L, Barakat S, Chevrou-Severac H, Druyts E
J Health Econ Outcomes Res
. 2021 Dec;
8(2):105-113.
PMID: 34963883
Wilson's disease (WD) is a rare inherited genetic disorder characterized by the progressive accumulation of copper in the brain, liver, and other major organ systems. To date, there have been...
5.
Yan K, Balijepalli C, Druyts E
Front Digit Health
. 2021 Oct;
3:667016.
PMID: 34713140
Historically healthcare has been delivered offline (e.g., physician consultations, mental health counseling services). It is widely understood that healthcare lags behind other industries (e.g., financial, transportation) whom have already incorporated...
6.
Ramakrishnan P, Yan K, Balijepalli C, Druyts E
Curr Med Res Opin
. 2021 Sep;
37(12):2089-2091.
PMID: 34511002
Diagnosis, prevention, management and treatment of acute and chronic medical conditions have improved with technological advancements in terms of scalability, efficacy, access, and personalized approach. Digital therapeutic applications (DTx) (Blue...
7.
Bischof M, Lorenzi M, Lee J, Druyts E, Balijepalli C, Dabbous O
Curr Med Res Opin
. 2021 Jul;
37(10):1719-1730.
PMID: 34236007
Objective: Onasemnogene abeparvovec, a one-time intravenous gene replacement therapy, and nusinersen, an antisense oligonucleotide that requires ongoing intrathecal administration, have been evaluated as treatments for spinal muscular atrophy (SMA) type...
8.
Balijepalli C, Yan K, Zoratti M, Franklin M, Druyts E
J Comp Eff Res
. 2021 Feb;
10(3):169-173.
PMID: 33541137
Composite renal end points and end stage renal disease (ESRD) are frequently included as prespecified secondary end points in the cardiovascular outcomes trials (CVOTs) of diabetes medications. We examined the...
9.
Franklin M, Druyts E
J Manag Care Spec Pharm
. 2020 Oct;
26(11):1464-1466.
PMID: 33119438
No funding supported the writing of this commentary. The authors have nothing to disclose.
10.
Desai K, Druyts E, Yan K, Balijepalli C
Pharmacoeconomics
. 2020 Sep;
38(11):1149-1151.
PMID: 32924091
No abstract available.